1.
Jain P, Romo CG, Khoury HJ, Kantarjian H, Cortes J. Clinical activity of ponatinib in patients with chronic myeloid leukemia in chronic phase with e1a2 transcripts. Haematologica [Internet]. 2013Nov.1 [cited 2026Nov.3];98(11):e141-e142. Available from: https://haematologica.org/article/view/6850